Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05077293 · ClinicalTrials.gov registry record
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 596
- Enrollment target
NCT05077293 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 596 participants.
The verdict
NCT05077293 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 596 participants
- Enrollment target
Study Summary
This is a feasibility study using a cross-over design to implement and compare a best practice alert (BPA) with an automated in-basket message to inform providers when a patient with heart failure and reduced ejection fraction (HFrEF) is not on appropriate medical therapy. The data from this pilot study will lead to a randomized controlled trial to compare the effectiveness of the BPA versus an automated in-basket message, versus usual care (no intervention).
Interventions
- OTHER Best Practice Alert (BPA)
- OTHER In-Basket Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 596 participants |
| Start Date | 2021-09-09 |
| Est. Completion | 2022-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05077293
The ClinicalTrials.gov registry entry for NCT05077293 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 596 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Best Practice Alert (BPA) is the first listed.
NCT05077293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05077293 about?
NCT05077293 is a clinical study titled "Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure". This is a feasibility study using a cross-over design to implement and compare a best practice alert (BPA) with an automated in-basket message to inform providers when a patient with heart failure and reduced ejection fraction (HFrEF) is not on appropriate medical therapy. The data from this pilot s...
What is the current status of trial NCT05077293?
This trial is currently completed. The enrollment target is 596 participants. The study started on 2021-09-09. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT05077293?
The interventions under investigation include: Best Practice Alert (BPA) (OTHER), In-Basket Message (OTHER).
Who is sponsoring clinical trial NCT05077293?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.